— Quest Diagnostics (NYSE: DGX) reported third quarter 2019 adjusted EPS of $1.76 vs. $1.71 expected.
Check below Quest Diagnostics Q3 2019 earnings infograph
— GAAP EPS of continuing operations increased 2.8% year-over-year to $1.56.
— Revenue grew 3.5% to $1.96 billion vs. $1.94 billion expected.
— Diagnostic Information Services revenue grew 3.7% to $1.88 billion.
— For fiscal 2019, revenue is expected to be approximately $7.72 billion.
— FY19 adjusted EPS is pegged to be between $6.45 and $6.50. Reported EPS from continuing operations is touted to be $5.48-5.43.
— DGX stock, which reached its 52-week high on Sept. 20, inched down 0.37% to $102.28 yesterday.
Most Popular
Mattel (MAT): A look at the toymaker’s expectations for the year
Shares of Mattel, Inc. (NASDAQ: MAT) were up slightly on Thursday. The stock has gained 20% year-to-date and 19% over the past three months. There is a level of optimism
Earnings Preview: Paychex likely to report higher Q1 revenue and profit
Paychex Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is all set to publish operating results for the first three months of fiscal 2024. The company has
DRI Earnings: Key quarterly highlights from Darden Restaurants’ Q1 2024 financial results
Darden Restaurants, Inc. (NYSE: DRI) reported first quarter 2024 earnings results today. Total sales increased 11.6% to $2.73 billion compared to the same period last year. Blended same-restaurant sales were
